Work Here?
Work Here?
Work Here?
ReNAgade Therapeutics focuses on developing RNA medicines to address the challenges of delivering therapies to specific tissues and creating an integrated therapeutic platform. The company has created a unique toolkit that enables precise correction of diseases on a large scale. Their proprietary delivery technologies allow for the reprogramming of cells to enhance gene expression, in collaboration with Orna Therapeutics. Unlike traditional gene therapy, which typically replaces defective genes, ReNAgade's approach aims to permanently correct these genes, making it a leader in the next generation of gene therapy. This technology also supports the insertion of larger genes or exons, allowing for more comprehensive treatment options. ReNAgade serves clients in the medical and healthcare sectors, generating revenue through joint ventures, licensing, and the potential development of its own therapeutic products.
Company Stage
Series A
Employees
51-200
Industries
Biotechnology, Healthcare
Total Funding
$300M
Headquarters
N/A
Founded
2021
Help us improve and share your feedback! Did you find this helpful?
Find jobs on Simplify and start your career today